Beneficial effects of adjuvant Intravitreal Bevacizumab injection on outcomes of Ahmed glaucoma valve implantation in patients with Neovascular glaucoma: Systematic literature review

Journal of Ocular Pharmacology and Therapeutics

Volumn 31, Issue 4, 2015, Pages 198-203

  Hwang, Hyung Bin ^a   Han, Jae Wook ^a   Yim, Hye Bin ^a   Lee, Na Young ^a  

^a Bupyeong gu   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; ANGIOGENESIS INHIBITOR; PHARMACEUTICAL VEHICLES AND ADDITIVES;

ADJUVANT THERAPY; AHMED VALVE; CHOROID DETACHMENT; CHOROID HEMORRHAGE; CORNEA DISEASE; DRUG EFFICACY; HUMAN; HYPHEMA; HYPOTONY MACULOPATHY; INTRAOCULAR PRESSURE; META ANALYSIS; NEOVASCULAR GLAUCOMA; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; VITREOUS HEMORRHAGE; AGED; FEMALE; GLAUCOMA DRAINAGE IMPLANT; GLAUCOMA, NEOVASCULAR; INTRAVITREAL DRUG ADMINISTRATION; MALE; MIDDLE AGED; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADJUVANTS, PHARMACEUTIC; AGED; ANGIOGENESIS INHIBITORS; BEVACIZUMAB; FEMALE; GLAUCOMA DRAINAGE IMPLANTS; GLAUCOMA, NEOVASCULAR; HUMANS; INTRAOCULAR PRESSURE; INTRAVITREAL INJECTIONS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84929658092     PISSN: 10807683     EISSN: 15577732     Source Type: Journal    
DOI: 10.1089/jop.2014.0108     Document Type: Review

References (22)

1. Aiello, L.P., Avery, R.L., Arrigg, P.G., et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N. Engl. J. Med. 331:1480-1487, 1994.
2. Boyd, S.R., Zachary, I., Chakravarthy, U., et al. Correlation of increased vascular endothelial growth factor with neovascularization and permeability in ischemic central vein occlusion. Arch. Ophthalmol. 120:1644-1650, 2002.
3. Spaide, R.F., and Fisher, Y.L. Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage. Retina. 26:275-278, 2006.
4. Iturralde, D., Spaide, R.F., Meyerle, C.B., et al. Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-Term study. Retina. 26:279-284, 2006.
5. Yazdani, S., Hendi, K., and Pakravan, M. Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma. J. Glaucoma. 16:437-439, 2007.
6. Silva Paula, J., Jorge, R., Alves Costa, R., Rodrigues Mde, L., and Scott, I.U. Short-Term results of intravitreal bevacizumab (Avastin) on anterior segment neovascularization in neovascular glaucoma. Acta Ophthalmol. Scand. 84: 556-557, 2006.
7. Iliev, M.E., Domig, D., Wolf-Schnurrbursch, U., Wolf, S., and Sarra, G.M. Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma. Am. J. Ophthalmol. 142:1054-1056, 2006.
8. Wakabayashi, T., Oshima, Y., Sakaguchi, H., et al. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases. Ophthalmology. 115:1571-1580, 1580 e1571-e1573, 2008.
9. Moraczewski, A.L., Lee, R.K., Palmberg, P.F., Rosenfeld, P.J., and Feuer, W.J. Outcomes of treatment of neovascular glaucoma with intravitreal bevacizumab. Br. J. Ophthalmol. 93:589-593, 2009.
10. Higgins, J.P.T., Green, S., and Cochrane Collaboration. Cochrane handbook for systematic reviews of interventions. Chichester: Wiley-Blackwell; 2008.
11. Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., and Group, P. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Ann. Intern. Med. 151:264-269, W264, 2009.
12. Cheng, J.W., Cai, J.P., Li, Y., and Wei, R.L. Intraoperative mitomycin C for nonpenetrating glaucoma surgery: a systematic review and meta-analysis. J. Glaucoma. 20:322-326, 2011.
13. Downs, S.H., and Black, N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J. Epidemiol. Community Health. 52: 377-384, 1998.
14. Mahdy, R.A., Nada, W.M., Fawzy, K.M., and Alnashar, H.Y., Almosalamy SM. Efficacy of intravitreal bevacizumab with panretinal photocoagulation followed by Ahmed valve implantation in neovascular glaucoma. J. Glaucoma. 22:768-772, 2013.
15. Eid, T.M., Radwan, A., el-Manawy, W., and el-Hawary, I. Intravitreal bevacizumab and aqueous shunting surgery for neovascular glaucoma: safety and efficacy. Can. J. Ophthalmol. 44:451-456, 2009.
16. Ma, K.T., Yang, J.Y., Kim, J.H., et al. Surgical results of Ahmed valve implantation with intraoperative bevacizumab injection in patients with neovascular glaucoma. J. Glaucoma. 21:331-336, 2012.
17. Arcieri, E.S., Paula, J.S., Jorge, R., et al. Efficacy and safety of intravitreal bevacizumab in eyes with neovascular glaucoma undergoing ahmed glaucoma valve implantation: 2-year follow-up. Acta Ophthalmol. 2014.
18. Sevim, M.S., Buttanri, I.B., Kugu, S., Serin, D., and Sevim, S. Effect of intravitreal bevacizumab injection before Ahmed glaucoma valve implantation in neovascular glaucoma. Ophthalmologica. 229:94-100, 2013.
19. Zhou, M.W., Wang, W., Huang, W.B., et al. Adjunctive with versus without intravitreal bevacizumab injection before Ahmed glaucoma valve implantation in the treatment of neovascular glaucoma. Chin. Med. J.126:1412-1417, 2013.
20. Tripathi, R.C., Li, J., Tripathi, B.J., Chalam, K.V., and Adamis, A.P. Increased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma. Ophthalmology. 105:232-237, 1998.
21. Kahook, M.Y., Schuman, J.S., and Noecker, R.J. Intravitreal bevacizumab in a patient with neovascular glaucoma. Ophthalmic Surg. Lasers Imaging. 37:144-146, 2006.
22. Grewal, D.S., Jain, R., Kumar, H., and Grewal, S.P. Evaluation of subconjunctival bevacizumab as an adjunct to trabeculectomy a pilot study. Ophthalmology. 115:2141-2145 e2142, 2008.